Mrs. fangyan He | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Mrs. fangyan He | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Senior Experimentalist at Yunnan University of Traditional Chinese Medicine, China

He Fangyan is a distinguished researcher specializing in the pharmacodynamics and pharmacokinetics of traditional Chinese medicine. Currently serving as a Senior Experimentalist at Yunnan University of Traditional Chinese Medicine, she has led multiple high-impact studies focusing on ischemic stroke mechanisms and brain pharmacokinetics. With a commitment to advancing neuropharmacology, she has secured prestigious research grants, contributed to key scientific advancements, and developed innovative methodologies in cerebral ischemia treatment. Her expertise extends to drug metabolism, blood-brain barrier protection, and targeted drug delivery, making her a prominent figure in the field. Through her patents, publications, and ongoing research, she continues to bridge the gap between traditional Chinese medicine and modern pharmacological science.

Professional Profile

Education

He Fangyan holds an advanced degree in pharmacology and traditional Chinese medicine research, equipping her with interdisciplinary expertise in both experimental and clinical pharmacokinetics. She has undergone rigorous training in drug absorption, metabolism, and pharmacodynamics, particularly focusing on ischemic stroke therapies. Her academic background includes specialized studies in cerebral ischemia-reperfusion injury and neuroprotection, which laid the foundation for her innovative research contributions. She has further enhanced her knowledge through postgraduate research projects, technical training in pharmacological analysis, and collaborations with leading scientists in neurological drug development. Her education has provided her with a strong analytical and methodological foundation, enabling her to conduct cutting-edge research in traditional Chinese medicine’s role in stroke management.

Professional Experience

With extensive experience in experimental pharmacology and neuroscience, He Fangyan has held a senior research position at Yunnan University of Traditional Chinese Medicine, leading multiple research projects funded by national and provincial grants. She has played a pivotal role in advancing traditional Chinese medicine applications for stroke treatment, particularly through the study of Gastrodia’s neuroprotective effects. Over the years, she has worked on high-impact studies integrating brain microdialysis, PK/PD modeling, and oxidative stress mechanisms. In addition to academic research, she has contributed to methodology development in neuropharmacology, ensuring precise drug targeting and evaluation of traditional medicine compounds. Her professional contributions also extend to mentoring young researchers and fostering interdisciplinary collaborations, strengthening the field of pharmacokinetics and neuroprotection.

Research Interests

He Fangyan’s primary research interests revolve around cerebral ischemia, blood-brain barrier protection, and pharmacokinetics of traditional Chinese medicine compounds. She is particularly focused on understanding the mechanisms of ischemic stroke and the therapeutic potential of Gastrodia-derived compounds in treating oxidative stress-induced brain damage. Her studies employ microdialysis techniques, drug metabolism analysis, and neuroprotective compound development, making significant contributions to stroke research. She is also deeply invested in the translation of traditional Chinese medicine principles into modern pharmacological applications, aiming to bridge ancient remedies with contemporary scientific methodologies. Additionally, she explores novel drug delivery systems and prodrug mechanisms, ensuring targeted treatment with minimal side effects for cerebrovascular diseases.

Awards and Honors

He Fangyan has been recognized for her outstanding contributions to traditional Chinese medicine research and neuropharmacology. She has received funding from prestigious institutions such as the National Natural Science Foundation of China and the Yunnan Science and Technology Department, reflecting the significance of her work. Her patented innovations in cerebral ischemia treatment have earned acclaim, contributing to advancements in stroke therapy. She has also published extensively in SCI-indexed journals, further solidifying her academic reputation. As a key figure in pharmacokinetics and stroke research, she has been invited to speak at academic conferences and collaborate on national research initiatives. Her dedication to scientific progress and innovation continues to garner recognition, positioning her as a leading researcher in the field of traditional Chinese medicine and neuroscience.

Conclusion

He Fangyan is a strong candidate for the Best Researcher Award due to extensive contributions to pharmacokinetics and stroke research, significant grant funding, patents, and high-impact journal publications. Strengthening industry ties, international collaborations, and academic outreach could further solidify eligibility for top-tier research awards.

Publications Top Noted

  • He, F., Feng, J., Sun, H., Xu, Y., Yan, H., Song, X., Wang, Y., Li, X., & Lin, Q. (2024). Protective Effect of Protocatechuic Aldehyde on Cerebral Ischemia/Reperfusion Injury in Rats through Blood–Brain Barrier Protection. Bulletin of Experimental Biology and Medicine. https://doi.org/10.1007/s10517-024-06264-z

  • He, F., Xu, C., Feng, J., Sun, H., Yan, M., Yang, Q., Zhou, X., Yang, J., & Lin, Q. (2024). Pharmacokinetics of 4-Hydroxybenzaldehyde in Normal and Cerebral Ischemia–Reperfusion Injury Rats Based on Microdialysis Technique. European Journal of Drug Metabolism and Pharmacokinetics. https://doi.org/10.1007/s13318-023-00863-3

  • He, F., Ma, C., Feng, J., Li, X., Xia, S., Lin, Q., Dai, R., & He, F. (2021). Angiogenesis effects of 4-methoxy benzyl alcohol on cerebral ischemia-reperfusion injury via regulation of VEGF-Ang/Tie2 balance. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2021-0118

  • He, F., Dai, R., Zhou, X., Li, X., Song, X., Yan, H., Meng, Q., Yang, C., & Lin, Q. (2019). Protective effect of 4-Methoxy benzyl alcohol on the neurovascular unit after cerebral ischemia reperfusion injury. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2019.109260

  • He, F., Duan, X., Dai, R., Li, Y., & Lin, Q. (2017). Protective Effect of 4-Methoxy Benzyl Alcohol on the Blood–Brain Barrier after Cerebral Ischemia Reperfusion Injury. Journal of Stroke and Cerebrovascular Diseases. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.01.018

 

Simon Nyarko | Pharmaceutics Award | Young Scientist Award

Mr. Simon Nyarko | Pharmaceutics Award | Young Scientist Award

Researcher, Kwame Nkrumah University of Science and Technology, Ghana

Simon Nyarko is a Pharmaceutics graduate with a Master’s from Kwame Nkrumah University of Science and Technology, Ghana. 🌟 His research focuses on drug quality assessment and microbial studies. As a Deputy Ambassador for Synthetic Biology Africa, 🧬 he fosters partnerships in Ghana’s scientific community. Simon’s diverse experience spans teaching, research, and pharmaceutical sales. 📚💼 Passionate about community engagement, he volunteers in educational initiatives and charity work. Simon’s dedication earned him accolades like the CPHIA Abstract Travel Grant and the GNPC Scholarship. 🏆 He’s published in esteemed journals like Advances in Pharmacological and Pharmaceutical Sciences and Asian Journal of Pediatric Research. Simon thrives at the intersection of science and service, striving to make impactful contributions to healthcare and society. 🌍

Profile

Orcid

Education  🎓

Simon Nyarko holds a Master of Philosophy in Pharmaceutics from Kwame Nkrumah University of Science and Technology, Ghana. His thesis focused on assessing the quality of artemether-lumefantrine tablets and suspensions. 📊 Previously, he earned a Bachelor of Science in Biological Sciences from the University of Education, Winneba, where he conducted research on microbial load and antibiotic resistance. 🧫🔬

Experience  💼

Simon’s experience encompasses various roles, from being a Medical Sales Representative to a Personal Assistant in Public Health. He’s adept at teaching and research, having served as a Biology Tutor and Graduate Student. 💡 Currently, he acts as a Deputy Ambassador for Synthetic Biology Africa, fostering collaborations and awareness. 🌱 Simon’s proactive approach and communication skills have facilitated his success in diverse professional environments. 🌐

Research Interests  🔍

Simon’s research interests lie in pharmaceutical quality assessment, microbiology, and drug development. He’s proficient in analytical techniques like HPLC and microbiological assays. 💊🔬 His work explores green methodologies for drug analysis and antimicrobial resistance patterns. Simon is keen on contributing to advancements in drug formulation and quality control, addressing global health challenges. 🌍

Awards 🏆

Simon has been honored with prestigious awards like the CPHIA Abstract Travel Grant and the GNPC Scholarship. He’s also received recognition for academic excellence from institutions like Kwame Nkrumah University of Science and Technology and the University of Education, Winneba. 🌟 Simon’s commitment to education and community service has earned him accolades and scholarships, affirming his dedication to making a positive impact. 🌟

Publications Top Notes 📚

“Investigating the Presence of Falsified and Poor-Quality Fixed-Dose Combination Artemether-Lumefantrine Pharmaceutical Dosage Forms in Kumasi, Ghana” (2024) Link 📊

“Development of the RP-HPLC Method for Simultaneous Determination and Quantification of Artemether and Lumefantrine in Fixed-Dose Combination Pharmaceutical Dosage Forms” (2024) Link

“A Review on the Application of Quality by Design Methodology in the Formulation, Development, and Evaluation of Fixed-Dose Combination Tablets” (2023) Link 📑